Indeed, by analyzing TCGA expression data in pancreatic cancer (PAAD dataset) we evidenced that FOXM1 high level is significantly related with bad overall survival (Fig. 5A), disease free survival (Fig. 5B) and with chemotherapy response (Fig. 5C) in PDAC patients. This evidence concerns the gene FOXM1 and pancreatic adenocarcinoma.